Type of Cancer
Skin and Soft Tissue
Phase
Division (Location)
Study ID
NCT#
Brief Description
A Randomized Phase II Study of Anti-PD1 Antibody [MK-3475 (Pembrolizumab)] Alone Versus Anti-PD1 Antibody Plus Stereotactic Body Radiation Therapy in Advanced Merkel Cell Carcinoma
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.